Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03254953
Other study ID # D0822
Secondary ID
Status Completed
Phase N/A
First received August 7, 2017
Last updated April 24, 2018
Start date April 19, 2017
Est. completion date March 2, 2018

Study information

Verified date April 2018
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a randomized controlled trial that compares 3 self-monitoring approaches for weight loss. GoalTracker is a standalone, technology-based intervention using a commercial smartphone app (MyFitnessPal) and email.

The investigators hypothesize that the group that delays diet tracking and receives additional intervention components (weekly personalized feedback, skills training, and action plans) will have greater weight loss at the end of the 12-week intervention and at 6-month followup, compared to (a) an intervention group that simultaneously tracks weight and diet for all 12 weeks and receives the same additional components, and (b) a control group that tracks only diet.


Description:

This study will examine whether a digital health intervention (GoalTracker) can promote weight loss among adults who are overweight or obese. Engagement in self-monitoring often declines over time, which is then associated with suboptimal weight loss. Finding ways to improve self-monitoring engagement, particularly in the first month of treatment, is needed. Promoting mastery, self-efficacy, and self-regulatory skills may help with maintaining high engagement.

The investigators aim to enroll 105 participants. All groups are asked to self-monitor daily on their smartphone using the free commercial mobile application MyFitnessPal over the course of the 12-week intervention.

Specifically, the study aims to...

1. Determine the effect of a Sequential self-monitoring intervention, compared to a Simultaneous self-monitoring intervention on weight change, caloric intake change, and proportion of individuals achieving 5% weight loss.

2. Determine the effect of the Sequential self-monitoring intervention, compared to the Control, on the same variables.

3. Compare self-monitoring engagement by intervention arm.

4. Examine the relation between self-monitoring engagement and weight loss.

5. Investigate theoretical mediators (self-efficacy, mastery, and self-regulation) on the relation between treatment arm and weight change.


Recruitment information / eligibility

Status Completed
Enrollment 105
Est. completion date March 2, 2018
Est. primary completion date December 11, 2017
Accepts healthy volunteers No
Gender All
Age group 21 Years to 65 Years
Eligibility Inclusion Criteria:

- ages 21-65 years old

- Body Mass Index (BMI) 25-45 kg/m2

- interested in losing weight through dietary change

- current use of iPhone or Android smartphone

- current use of email address

- has daily access to a bathroom scale

- no recent weight loss (=10 lbs) in the past 6 months

- able to read and write in English

- able to attend 3 in-person evaluation visits at Duke University in Durham, North Carolina over a 3-month period

Exclusion Criteria:

- current participation in another weight loss treatment

- currently pregnant or planning to become pregnant within study period, or < 1 year post-partum

- history of cardiovascular event, eating disorder, diabetes mellitus, hypothyroidism, cancer, end stage renal disease

- current uncontrolled hypertension

- use of the MyFitnessPal app to track food in the past 6 months

- Former or planned bariatric surgery

- current use of medication (e.g., lithium, steroids, anti-psychotics)

- use of weight loss medication in past 6 months

- profound cognitive, developmental, or psychiatric disorders or recent hospitalization in a psychiatric facility

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
self-monitoring of body weight
- weigh daily for 3 months and track their weight using the MyFitnessPal mobile app
self-monitoring of diet
track their diet (food and drinks) daily using the MyFitnessPal mobile app when they are asked to track diet will vary based on the arm
weekly personalized feedback + lessons + action plans
- these are additional evidence-based intervention components

Locations

Country Name City State
United States Duke University Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Duke University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Physical Activity Paffenbarger Activity Questionnaire (7 items) will assess physical activity. Baseline, 3 months
Other Sleep Quality Medical Outcomes Study (MOS) Sleep (12 items) will assess sleep quality. Baseline, 1 month, 3 months
Other Perceived Stress Perceived Stress Scale (10 items) Baseline, 3 months
Other Depressive Symptoms Patient Health Questionnaire (PHQ-8) will assess depressive symptoms. Baseline, 1 month, 3 months
Other Health-Related Quality of Life EuroQol-5 Dimension (EQ-5D) (5 items) will assess health-related quality of life. Baseline, 1 month, 3 months
Primary Change in Weight Weight will be collected in kilograms using a calibrated digital scale Baseline, 1 month, 3 months
Secondary Proportion of Individuals Achieving = 5% Weight Loss Weight will be collected in kilograms using a calibrated digital scale Baseline to 3 months
Secondary Change in Caloric Intake Caloric intake will will be assessed using the Automated Self-Administered 24-hour Dietary Intake Assessment (ASA24), an online dietary recall tool developed by the National Cancer Institute Baseline, 3 months
Secondary Change in Weight at 6 Months At 6-months (i.e., 3 months post-intervention), self-reported weight will be collected 6 months
Secondary Self-Monitoring Engagement Frequency of self-monitoring weight and diet; Consistency of self-monitoring weight and diet Baseline to 1-month and 3 months
Secondary Self-Efficacy Weight Efficacy Lifestyle Questionnaire (WEL) (20 items) will assess self-efficacy for eating. Separate surveys that were adapted will assess self-efficacy for self-monitoring of diet and weight. Baseline, 1 month, 3 months
Secondary Mastery The Automaticity subscale of The Self-Report Habit Index (SRHI) will assess mastery of self-monitoring diet and weight (4 items each). Baseline, 1 month, 3 months
Secondary Self-Regulation The Three Factor Eating Questionnaire-R18 (TFEQ-R18) (18 items) will assess self-regulation for controlled eating. Separate surveys that were adapted will assess self-regulation for self-monitoring of diet and weight. Baseline, 1 month, 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2